Evidence map›Paper›PMID 24498026›Full record

ArticlePloS one2014

Chemical rescue and inhibition studies to determine the role of Arg301 in phosphite dehydrogenase.

John E Hung, Emily J Fogle, Neha Garg, Jonathan R Chekan, Satish K Nair, Wilfred A van der Donk

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Metabolic Engineering ofMicroorganisms · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John E HungDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Emily J FogleDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Neha GargDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Jonathan R ChekanDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Satish K NairDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America ; Center for Biophysics and Computational Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
Wilfred A van der DonkDepartment of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America ; Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America ; Howard Hughes Medical Institute, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America.
University of Illinois Urbana-Champaign · USHoward Hughes Medical Institute · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Phosphite dehydrogenase (PTDH) catalyzes the NAD(+)-dependent oxidation of phosphite to phosphate. This reaction requires the deprotonation of a water nucleophile for attack on phosphite. A crystal structure was recently solved that identified Arg301 as a potential base given its proximity and orientation to the substrates and a water molecule within the active site. Mutants of this residue showed its importance for efficient catalysis, with about a 100-fold loss in k cat and substantially increased K m,phosphite for the Ala mutant (R301A). The 2.35 Å resolution crystal structure of the R301A mutant with NAD(+) bound shows that removal of the guanidine group renders the active site solvent exposed, suggesting the possibility of chemical rescue of activity. We show that the catalytic activity of this mutant is restored to near wild-type levels by the addition of exogenous guanidinium analogues; Brønsted analysis of the rates of chemical rescue suggests that protonation of the rescue reagent is complete in the transition state of the rate-limiting step. Kinetic isotope effects on the reaction in the presence of rescue agents show that hydride transfer remains at least partially rate-limiting, and inhibition experiments show that K i of sulfite with R301A is ∼400-fold increased compared to the parent enzyme, similar to the increase in K m for phosphite in this mutant. The results of our experiments indicate that Arg301 plays an important role in phosphite binding as well as catalysis, but that it is not likely to act as an active site base.

Indexed as

MutationArginineBacterial ProteinsBinding SitesBiocatalysisCatalytic DomainCrystallography, X-RayGuanidinesHydrogen-Ion ConcentrationKineticsModels, MolecularNADNADH, NADPH OxidoreductasesPhosphatesPhosphitesProtein BindingArginineBacterial ProteinsGuanidinesNADNADH, NADPH OxidoreductasesNAD phosphite oxidoreductasePhosphatesPhosphitessodium sulfiteSulfites

Identifiers

PMID24498026
PMCPMC3909101
OpenAlexW2085419815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.